CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-16 | Nicholson John SVP & Chief Operating Officer | Sale | −4,879 | $82.94 | $405K | 387,657 |
| 2018-02-16 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −3,477 | $82.94 | $288K | 99,739 |
| 2018-02-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −2,875 | $82.94 | $238K | 80,261 |
| 2018-02-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Sale | −2,426 | $82.94 | $201K | 67,394 |
| 2018-01-31 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion | +120,000 | $11.34 | $1.4M | 392,536 |
| 2018-01-31 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion · Stock Option | −120,000 | 0 | ||
| 2018-01-22 | ROBIN HOWARD W President & CEO | Exercise or conversion | +83,333 | $11.34 | $945K | 333,268 |
| 2018-01-22 | ROBIN HOWARD W President & CEO | Sale | −83,333 | $75.82 | $6.3M | 249,935 |
| 2018-01-22 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −83,333 | 0 | ||
| 2018-01-04 | WINGER DENNIS L Director | Exercise or conversion | +33,750 | $11.97 | $404K | 77,000 |
| 2018-01-04 | WINGER DENNIS L Director | Exercise or conversion · Stock Option | −22,500 | 0 | ||
| 2018-01-04 | WINGER DENNIS L Director | Exercise or conversion · Stock Option | −11,250 | 0 | ||
| 2018-01-02 | KUEBLER CHRISTOPHER A Director | Exercise or conversion | +30,000 | $14.26 | $428K | 70,500 |
| 2018-01-02 | KUEBLER CHRISTOPHER A Director | Sale | −30,000 | $58.66 | $1.8M | 40,500 |
| 2018-01-02 | KUEBLER CHRISTOPHER A Director | Exercise or conversion · Stock Option | −30,000 | 0 | ||
| 2017-12-15 | ROBIN HOWARD W President & CEO | Grant or award | +60,500 | 249,935 | ||
| 2017-12-15 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +151,250 | 151,250 | ||
| 2017-12-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award | +10,400 | 71,402 | ||
| 2017-12-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +26,250 | 26,250 | ||
| 2017-12-15 | Nicholson John SVP & Chief Operating Officer | Grant or award | +26,000 | 272,536 |
Page 36 of 43 · 847 trades